Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
From Nkarta, Inc.
Via GlobeNewswire
Tickers NKTX
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
From Autolus Therapeutics plc
Via GlobeNewswire
Tickers AUTL
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Li-Cycle Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LICY
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers LICY
Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
From Aptose Biosciences, Inc.
Via GlobeNewswire
Tickers APTO TSX:APS
Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts
From Biomea Fusion, Inc.
Via GlobeNewswire
Tickers BMEA
ROSEN, LEADING INVESTOR COUNSEL, Encourages Expensify, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EXFY
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers EXFY
Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology
From Allogene Therapeutics, Inc.
Via GlobeNewswire
Tickers ALLO
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101
From Galapagos NV
Via GlobeNewswire
Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
From Corvus Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers CRVS
Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
From Century Therapeutics, Inc.
Via GlobeNewswire
Tickers IPSC
TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
From TScan Therapeutics, Inc.
Via GlobeNewswire
Tickers TCRX
NKLA FINAL DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nikola Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NKLA
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers NKLA
Flash News: OKX Wallet Now Integrated with NAVI and Offers Extra Yield For a Limited Time
From OKX
Via GlobeNewswire
Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
The UAE Pavilion Programs Emphasize Commitment to Innovation and Education
From The UAE PAVILION BLUE ZONE AT COP28
Via GlobeNewswire
Completion of the Third Tranche of Stellantis Share Buyback Program and Weekly Report (December 1-7, 2023)
From STELLANTIS N.V
Via GlobeNewswire
Tickers STLA
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
From CURE Media Group
Via GlobeNewswire
DOLLAR GENERAL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Dollar General Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers DG
ROSEN, A RESPECTED AND LEADING FIRM, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LPSN
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers LPSN
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MVST, MVSTW
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers MVST MVSTW
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers MDRX
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers OTLK
Pharvaris Presents Deucrictibant Clinical Data and Analysis of Endpoints for Trials of On-demand Treatment of HAE at the GA²LEN UCARE Conference 2023
From Pharvaris N.V.
Via GlobeNewswire
Tickers PHVS
ROSEN, NATIONAL TRIAL COUNSEL, Encourages British American Tobacco p.l.c Investors to Inquire About Securities Class Action Investigation – BTI
From The Rosen Law Firm PA
Via GlobeNewswire
Tickers BTI
Digital Asset Investment Management (DAIM) Wants Investors To Know That Licensed Advisors And Managers For Crypto Are Available
From Digital Asset Investment Management
Via GlobeNewswire
Constellation Brands Announces New Leadership Appointments
From Constellation Brands, Inc.
Via GlobeNewswire
Tickers STZ STZ-B
Fentress Global Challenge 2024 Invites Students to Pioneer the Future of Airport Design
From Fentress Architects
Via GlobeNewswire
Jianzhi Education Technology Group Company Limited Reports First Half 2023 Financial Results
From Jianzhi Education Technology Group Company Limited
Via GlobeNewswire
Tickers JZ
Publication Relating to a Transparency Notification
From Nyxoah
Via GlobeNewswire
Tickers NYXH
Safeguard Scientifics’ Board of Directors Declares Contingent Cash Dividend of $0.35 Per Share
From Safeguard Scientifics
Via GlobeNewswire
Tickers SFE
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.